Lotte Chemical Pakistan Limited (LOTCHEM) has reported a significantly challenging financial year for 2025, with its net profit plummeting by 58% and earnings per share (EPS) more than halving. A critical concern for investors is the dramatic shift from a robust positive operating cash flow to a negative figure, directly impacting shareholder returns as the company announced no dividend for the year.
Financial Performance Overview
The company's top line experienced a substantial contraction, with revenue from contracts with customers decreasing by 25.97% from PKR 109,299,177 thousand (PKR 109.3 billion) in 2024 to PKR 80,906,921 thousand (PKR 80.9 billion) in 2025. This significant reduction in sales indicates a challenging market environment, potentially due to weaker demand or lower product prices for its primary product, Purified Terephthalic Acid (PTA).
This decline in revenue directly impacted the bottom line. Net profit for the year fell sharply from PKR 2,642,473 thousand (PKR 2.64 billion) in 2024 to PKR 1,118,932 thousand (PKR 1.12 billion) in 2025. Consequently, basic and diluted Earnings Per Share (EPS) dropped from PKR 1.75 to PKR 0.74, representing a significant setback for shareholders.
Profitability margins also experienced considerable compression. The gross profit margin narrowed from 4.75% in 2024 to 3.80% in 2025, while the net profit margin declined from 2.42% to 1.38%. This suggests that despite efforts to manage costs, the company faced intense pressure on its pricing power or higher operational costs relative to sales.
Perhaps the most critical development for investors is the dramatic reversal in operating cash flow. From generating a healthy PKR 13,513,983 thousand (PKR 13.51 billion) in cash from operations in 2024, LOTCHEM recorded a negative operating cash flow of PKR (281,680) thousand (PKR 281.68 million) in 2025. This signals a significant challenge in converting sales into cash, potentially due to working capital management issues or slower collections from customers.
Total assets increased from PKR 42,040,942 thousand (PKR 42.04 billion) to PKR 47,802,570 thousand (PKR 47.80 billion). However, this growth was largely concentrated in current assets, specifically a notable increase in stock-in-trade (inventory) from PKR 6,746,190 thousand (PKR 6.75 billion) to PKR 9,091,174 thousand (PKR 9.09 billion) and trade debts from PKR 3,602,907 thousand (PKR 3.60 billion) to PKR 6,406,906 thousand (PKR 6.41 billion). Conversely, cash and bank balances decreased from PKR 8,833,047 thousand (PKR 8.83 billion) to PKR 6,828,351 thousand (PKR 6.83 billion). To manage liquidity, the company also utilized PKR 800,000 thousand (PKR 800 million) in new short-term financing.
Key Operational Drivers
While the detailed drivers for the revenue decline are not explicitly broken down by segment in the provided summary, the overall reduction points to a challenging market environment for PTA, LOTCHEM's primary product. The significant increase in inventory and trade debts suggests either an oversupply situation, weaker demand leading to slower sales, or challenges in collecting payments from customers. Other income, which provided a substantial boost in previous years, also saw a reduction from PKR 1,199,362 thousand (PKR 1.20 billion) in 2024 to PKR 635,691 thousand (PKR 635.69 million) in 2025, further impacting overall profitability.
Management Response and Shareholder Impact
In response to the challenging environment, payments for capital expenditure were reduced from PKR 1,555,386 thousand (PKR 1.56 billion) in 2024 to PKR 848,057 thousand (PKR 848 million) in 2025, indicating a more conservative approach to investment. The company's reliance on PKR 800,000 thousand (PKR 800 million) in new short-term financing, contrasting with a repayment of PKR 1,000,000 thousand (PKR 1 billion) in the previous year, highlights a shift towards liquidity management. Despite the increased financing, finance costs decreased from PKR 730,822 thousand (PKR 730.82 million) to PKR 554,628 thousand (PKR 554.63 million), potentially due to lower average debt levels or a favorable interest rate environment.
The most direct signal to shareholders is the Board's recommendation of "Nil" for cash dividend, bonus shares, right shares, or any other corporate action for the year ended 31 December 2025. This decision unequivocally underscores the difficult financial year and the company's imperative to preserve cash, especially given the negative operating cash flow.
Investor Outlook
LOTCHEM's 2025 results represent a significant setback, primarily driven by a sharp decline in sales and profitability, culminating in a concerning negative operating cash flow. Investors should closely monitor the company's ability to reverse this negative operating cash flow trend. Improvement in working capital management, particularly managing inventory levels and accelerating trade debt collections, will be crucial. The outlook for LOTCHEM will heavily depend on the dynamics of the PTA market, including international prices, demand-supply balance, and raw material costs. The absence of a dividend for 2025 highlights the immediate pressure on cash generation. Future dividend prospects will be contingent on a sustained turnaround in profitability and cash flow. Given the substantial drop in EPS and no dividend, the stock's valuation will likely remain under pressure. Investors should look for clear signs of operational improvement and a consistent return to positive cash generation before anticipating a recovery in shareholder returns.